Manufacturers with CEP certificate for APIs in Europe and Asia 2000-2020
The number of new manufacturers with Certificates of Suitability of Monographs of the European Pharmacopoeia (CEPs) was consistently higher for Asia than for Europe from 2000 through 2018. CEPs are proof certificates of an active pharmaceutical ingredient's (APIs) quality, and are used for drug approvals. This statistic illustrates the number of new and defunct manufacturers with valid CEPs for APIs in Europe and Asia, from 2000 to 2020.